China's Shanghai Fosun Pharmaceutical announced on May 9 that a subsidiary had agreed to provide manufacturing facilities upward of one billion COVID-19 vaccine doses in a joint venture with the German firm BioNTech, Reuters has reported.

China: Fosun Pharm Announces Joint Venture With With BioNTech to Make COVID-19 Vaccines

China

Environment, Science & Technology

China's Shanghai Fosun Pharmaceutical announced on May 9 that a subsidiary had agreed to provide manufacturing facilities upward of one billion COVID-19 vaccine doses in a joint venture with the German firm BioNTech, Reuters has reported. 

SITUATION REPORT

China: Fosun Pharm Announces Joint Venture With With BioNTech to Make COVID-19 Vaccines

Subscribe to view this article